Drug Profile
Isosorbide mononitrate-long-acting
Alternative Names: Elantan-LA; Elantan-longLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Schwarz Pharma
- Developer Somedico
- Class Heart failure therapies; Ischaemic heart disorder therapies; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Angina pectoris